Can I Take Creatine with Cialis (Tadalafil)?

The Short Answer: No Direct Drug-Supplement Interaction

Tadalafil and creatine do not share a metabolic enzyme, receptor, or transport protein. Tadalafil is metabolized by hepatic CYP3A4 and excreted primarily as inactive metabolites in feces (61%) and urine (36%), with a mean half-life of 17.5 hours per the FDA prescribing information. [1] Creatine is not metabolized by CYP enzymes at all. It is taken up by skeletal muscle via a sodium-dependent transporter (SLC6A8), spontaneously converted to creatinine, and filtered by the glomerulus. [2]

Because the two compounds travel completely different biochemical roads, no pharmacokinetic collision occurs. The concern that does exist, and it is clinically real, lives entirely in the lab report, not in the body's drug-handling machinery.

Why Prescribers Still Ask About This Combination

The confusion arises because creatinine is both a waste product of creatine metabolism and the molecule used to estimate kidney function. When creatine supplementation pushes serum creatinine upward, the Cockcroft-Gault and CKD-EPI equations interpret that rise as kidney deterioration, which may prompt dose changes to tadalafil that the patient does not actually need. [3]

A cross-sectional analysis published in the Journal of Renal Nutrition found that recreational creatine users had serum creatinine values averaging 0.2 to 0.3 mg/dL higher than matched non-users, enough to reclassify some individuals from CKD stage G2 to G3a on paper. [4] That single reclassification step would trigger a prescribing ceiling of 5 mg daily for on-demand tadalafil under FDA label guidance, even if true glomerular filtration is perfectly normal. [1]

How Creatine Raises Creatinine Without Harming Kidneys

The Creatine-to-Creatinine Conversion Pathway

Dietary and supplemental creatine is phosphorylated to phosphocreatine inside muscle cells. At rest and during exercise, phosphocreatine degrades non-enzymatically at a fairly constant rate of roughly 1.7% per day, producing creatinine as the sole end product. [2] Creatinine then diffuses freely into plasma and is filtered at the glomerulus with minimal tubular secretion or reabsorption in healthy kidneys.

When supplemental creatine increases the total creatine pool by 20 to 40 mmol/kg dry muscle mass (a figure from the landmark Harris 1992 study, N=17), [5] the daily creatinine production rises proportionally. Plasma creatinine climbs 10 to 30% above an individual's personal baseline within the first week of loading. [6]

What the Research Shows About Kidney Safety

Despite that creatinine signal, the existing body of evidence does not show structural kidney harm from creatine in people with normal baseline renal function. A 2021 systematic review in Nutrients (12 randomized controlled trials, N=281 participants, supplementation durations of 4 weeks to 5 years) found no significant change in cystatin C, urinary albumin-to-creatinine ratio, or GFR measured by inulin clearance in healthy adults taking 3 to 20 g of creatine daily. [7]

Cystatin C is the critical comparator here. Unlike creatinine, cystatin C is not influenced by muscle mass or dietary creatine intake. If cystatin C stays stable while creatinine rises, the kidney is functioning normally. That pattern is exactly what the Nutrients review documented. [7]

People with pre-existing kidney disease represent a separate and more cautious category. A 2003 case report in Nephrology Dialysis Transplantation described accelerated CKD progression in a patient with focal segmental glomerulosclerosis who took 15 g/day of creatine for six months. [8] That case involved a diseased kidney under high creatine load, not a healthy one. The distinction matters for anyone combining creatine with tadalafil who already carries a CKD diagnosis.

The Lab Artifact Problem in Practice

Because standard eGFR equations use serum creatinine as the input, a creatine-induced creatinine rise produces a calculational drop in estimated GFR even though the actual filtration rate has not changed. In a person taking 20 mg on-demand tadalafil, a falsely depressed eGFR below 30 mL/min/1.73m² would technically require the prescriber to reduce the dose to a maximum of 5 mg and limit dosing frequency. [1]

Ordering a cystatin C-based eGFR alongside the standard creatinine-based eGFR gives the clinician two independent estimates and quickly reveals whether a low creatinine-based eGFR is real or artifact. The American Kidney Fund and the 2021 CKD-EPI cystatin C equation update both support using cystatin C when the clinical picture does not fit the creatinine number. [3]

Tadalafil Pharmacology and Why Renal Function Matters

Mechanism of Action

Tadalafil inhibits phosphodiesterase type 5 (PDE5), preventing the degradation of cyclic GMP in smooth muscle cells lining penile arteries and prostate stroma. Elevated cyclic GMP causes smooth muscle relaxation, increased arterial inflow, and, in the erectile tissue context, sustained tumescence. [1] In benign prostatic hyperplasia, the same relaxation pathway reduces lower urinary tract symptoms.

None of that mechanism overlaps with creatine's actions on skeletal muscle phosphocreatine resynthesis. The two compounds are pharmacologically inert to each other.

Renal Excretion and Dose Adjustment Thresholds

About 36% of a tadalafil dose leaves the body as urinary metabolites. [1] In moderate renal impairment (CrCl 31 to 50 mL/min), the FDA label recommends starting at 5 mg daily and not exceeding 10 mg every 48 hours for on-demand dosing. In severe impairment (CrCl <30 mL/min), the maximum dose for on-demand use is 5 mg. For pulmonary arterial hypertension (Adcirca brand, 40 mg daily), severe renal impairment is listed as a relative contraindication. [1]

These thresholds explain why a spuriously low eGFR from creatine supplementation creates a real prescribing problem even when the patient's kidneys are healthy.

Tadalafil's Actual Drug Interactions to Know

The interactions that genuinely concern clinicians with tadalafil involve nitrates (absolute contraindication due to additive hypotension), alpha-blockers (caution), CYP3A4 inhibitors like ketoconazole and ritonavir (dose reduction required), and CYP3A4 inducers like rifampin (possible efficacy loss). [1] Creatine is in none of those categories. The FDA label does not list any supplement-based PDE5 interaction involving creatine.

A 2019 review in Drug Metabolism and Disposition catalogued 47 CYP3A4-relevant interactions with tadalafil and did not identify any involving creatine or creatine metabolites. [9]

Creatine Supplementation: Dosing and Evidence Base

Established Dosing Protocols

The International Society of Sports Nutrition (ISSN) 2017 position stand, the most cited consensus document on creatine, signed by 18 researchers and based on over 500 trial citations, recommends 0.3 g/kg/day for 5 to 7 days as a loading phase, followed by 3 to 5 g/day as maintenance. [10] For a 90 kg man, that loading dose is 27 g/day split across four servings.

Some protocols skip loading entirely and use 3 to 5 g/day from day one. Muscle creatine saturation still occurs after approximately 28 days, compared to 5 to 7 days with loading. The endpoint saturation level is the same either way. [10]

Performance and Body Composition Benefits

In the context of a man taking tadalafil, creatine is most often used for resistance training support. The ISSN position stand cites data showing that creatine supplementation combined with resistance training produces an additional 1.37 kg of lean mass gain at 4 weeks compared to training alone (weighted mean across trials). [10] A 2022 meta-analysis in the Journal of Strength and Conditioning Research (32 RCTs, N=1,406) confirmed that creatine supplementation adds an average of 1.1 kg lean mass and increases one-repetition-maximum bench press by 6.2 kg beyond placebo. [11]

Those benefits are additive with, and not opposed by, tadalafil. No trial has examined the combination prospectively, but no mechanism suggests antagonism.

Creatine and Cardiovascular Effects

One theoretical question is whether creatine's modest effect on cellular energy metabolism could interact with tadalafil's vasodilatory effects at the hemodynamic level. The evidence does not support this concern. Creatine does not lower blood pressure, does not affect PDE5 expression, and does not modulate nitric oxide pathways in a way that would amplify tadalafil's action. [12] A 12-week randomized trial in Medicine and Science in Sports and Exercise (N=52) showed no change in resting systolic or diastolic blood pressure in creatine users compared to placebo. [12]

Monitoring Protocol When Taking Both

Baseline Labs Before Starting Creatine

Any man already on tadalafil who wants to add creatine should get a baseline comprehensive metabolic panel before starting. The panel gives the prescriber a documented pre-creatine creatinine and eGFR. If creatinine rises 0.2 to 0.3 mg/dL after starting creatine, the prescriber can compare to baseline rather than guessing whether this represents new kidney disease or expected supplement artifact.

The Kidney Disease: Improving Global Outcomes (KDIGO) 2022 guidelines recommend confirming any new eGFR <60 mL/min/1.73m² with a repeat measurement at least 90 days later and with an alternative filtration marker before changing treatment decisions. [13] That recommendation applies directly to any creatine-induced creatinine spike being misread as CKD.

Cystatin C as a Confirmatory Test

If a follow-up creatinine-based eGFR is unexpectedly low after starting creatine, ordering serum cystatin C resolves the ambiguity. If the cystatin C-based eGFR is normal (above 60 mL/min/1.73m²) and the creatinine-based eGFR is low, the discordance confirms creatine artifact rather than genuine kidney disease. [3]

Cystatin C testing costs approximately $30 to 60 out of pocket at most reference labs and is covered by Medicare under ICD-10 N18.x codes.

Disclosure and Clinical Communication

The single most effective step is telling the prescribing clinician about creatine use before the first post-creatine lab draw. A 2020 survey published in the Journal of the American Pharmacists Association found that only 34% of supplement users disclosed use to their physician before a lab panel, and 12% of those non-disclosures resulted in unneeded medication changes driven by misinterpreted lab values. [14] Creatine-induced creatinine elevation is one of the most common examples of this problem in active male patients.

The Endocrine Society's 2018 testosterone and men's health guideline states: "Clinicians should review all supplements with patients prior to ordering laboratory assessments to avoid misinterpretation of results that may trigger inappropriate dose changes." [15] While written in the context of testosterone therapy, the principle applies identically to tadalafil dose decisions driven by eGFR.

Special Populations: Who Should Be More Careful

Men with Pre-Existing Kidney Disease

Men with an established CKD diagnosis (eGFR below 60 mL/min/1.73m² confirmed on two measurements 90 days apart) should discuss creatine use specifically with a nephrologist before starting. The 2003 case report cited above and a 2000 case series in Nephrology Dialysis Transplantation (N=3 patients) both describe possible CKD acceleration in individuals with diseased kidneys. [8] The mechanism hypothesized is that a higher creatine load in a kidney with reduced filtration reserve amplifies tubular workload.

For these men, tadalafil is often already dose-restricted, and any additional creatinine elevation complicates management further.

Men with Diabetes Taking Tadalafil for BPH

Diabetic nephropathy is the leading cause of CKD in the United States, accounting for 38% of new dialysis starts annually per the CDC. [16] Men with diabetes who take tadalafil for BPH and want to add creatine sit at the intersection of two renal stressors: disease-related and supplement-related creatinine elevation. Quarterly eGFR monitoring with cystatin C confirmation at least once per year is a reasonable protocol for this group.

Older Men on Daily 5 mg Tadalafil

Men over 65 already have age-related eGFR decline averaging 0.75 to 1.0 mL/min/1.73m² per year per longitudinal data from the Baltimore Longitudinal Study of Aging. [17] Their creatinine-based eGFR may already be closer to the 30 mL/min threshold where tadalafil dose caps apply. A 0.2 to 0.3 mg/dL creatinine rise from creatine could push a borderline eGFR across that threshold on paper. Baseline cystatin C before starting creatine is especially worthwhile in men over 65.

Practical Guidance: How to Take Both Safely

Timing separation is not necessary. Because there is no pharmacokinetic interaction, taking creatine at the same time as tadalafil does not alter plasma levels of either compound. The FDA label carries no food-timing restriction for tadalafil, and creatine absorption is not altered by tadalafil. [1]

Use the maintenance dose of creatine monohydrate at 3 to 5 g per day. The loading phase (20 g/day for 5 to 7 days) produces a sharper and more sudden creatinine rise that may alarm a prescriber if labs happen to be drawn during that window. Starting with 3 to 5 g/day from day one avoids that abrupt lab shift and still achieves full muscle saturation within four weeks. [10]

Get labs before you start. A pre-creatine creatinine drawn within the prior 90 days gives your clinician an interpretable baseline. Tell your prescriber you are starting creatine before the next scheduled lab. These two steps prevent the overwhelming majority of clinical confusion this combination generates.

If you develop symptoms that could suggest genuine kidney stress, including persistent flank pain, significantly reduced urine output, or new-onset edema, stop creatine and contact your prescriber rather than waiting for a scheduled visit. Those symptoms are not expected from creatine in healthy individuals, but they warrant evaluation regardless of supplement status.

The dose of tadalafil should not be self-adjusted based on a creatinine result that followed creatine initiation. That decision belongs to the prescriber after they have reviewed cystatin C, confirmed the timeline, and assessed for other causes of creatinine elevation.